StarZero All shows Try the podcast clipper →

Josh Israel

Co-founder & CEO, Hale Therapeutics · 1 appearance on the record.

computed by AI from the episodes · how this works → · full disclaimer →

founderexecutiveinvestorabout.me/israeljosh ↗

Josh Israel is the co-founder and CEO of Hale Therapeutics, formerly Hava Health, which develops a medical vaporizer and software for smoking cessation. He previously co-founded Thrill Group, which was acquired by Shaadi.com in 2016.

9statements → 6claims → 4claims resolved → 75%fully supported → 3.89/5average certainty → 1.67/5average debate potential → 1said about them ↓

3 supported 1 partly supported 0 contradicted 1 not yet assessed 1 not checkable as stated how the 6 claims stand · each chip opens the sources

2 predictions · 4 assertions · 3 disclosures · every statement was checked. The predictions and assertions are the 6 claims: statements the public record can support or contradict. 4 are resolved, 1 is not yet assessed, and 1 names no date, number or outcome precise enough to check. Everything else (opinions, insights, what ifs, disclosures) can never be settled by the record, so it carries no assessment.

The record, in short

What the tape says about how Josh argues and how the claims held up. Everything they said, and everything said about them, is in the tabs below.

Their most notable supported claim

Assertion Supported
Israel says vaping illnesses stem from black-market THC, not nicotine vapes
“If you look at nicotine-based vapes, there hasn't been any directly related health crisis or crises that have sprung up because of them. It's all been linked to THC and vitamin E or vitamin A acetate and the THC kind of black market pods.”
Josh Israel Mar 3, 2025 ▶ 19:30 #79 The Anti-JUUL

How they sound: not measured why? →

We measure speaking style by listening to the audio itself, and a fair number needs at least 2,000 words from one person on tape we have measured. There is too little of Josh Israel on measured tape to publish a rate. This says nothing about how they speak.

Everything Josh Israel said on the Pitch that made the record, most notable first. Filter by type, assessment or year in the ledger →

Assertion Supported
Israel says vaping illnesses stem from black-market THC, not nicotine vapes
“If you look at nicotine-based vapes, there hasn't been any directly related health crisis or crises that have sprung up because of them. It's all been linked to THC and vitamin E or vitamin A acetate and the THC kind of black market pods.”
Josh Israel Mar 3, 2025 ▶ 19:30 #79 The Anti-JUUL
Assertion Supported
Israel says nicotine patch and gum success rates are 5% to 15%
“Like, if you look at the success rates for the patch of the gum, it's five to 15%. People try seven to eight times with those products on average to quit. They don't work.”
Josh Israel Mar 3, 2025 ▶ 4:48 #79 The Anti-JUUL
Prediction Open · timeframe Mar 2028
Israel expects Hava Health's time to market to be 36 months
“So total time to market, estimating around 36 months.”
Josh Israel Mar 3, 2025 ▶ 9:28 #79 The Anti-JUUL
Disclosure
Israel says Hava is contractually committed against taking Big Tobacco capital
“What we did in his advisory agreement, you know, we made it explicitly clear that we're a smoking cessation product and we will never take capital from big tobacco.”
Josh Israel Mar 3, 2025 ▶ 14:40 #79 The Anti-JUUL
Assertion Supported
Israel says pre-2016 vape makers like Juul launched with zero FDA testing
“They haven't done any tests at all. It was like a pretty much a free for all pre-two 1016 where anybody could release a product and they were grandfathered in.”
Josh Israel Mar 3, 2025 ▶ 20:20 #79 The Anti-JUUL
Disclosure
Israel says Hava closed $1M pre-seed and seeks $250K oversubscription
“I'm happy to say that we recently closed our pre-seed round of one million dollars, so I'm here today to look at potentially oversubscribing that round with investments up to 250,000 dollars to further product development while we go through our preclinical ph…”
Josh Israel Mar 3, 2025 ▶ 3:38 #79 The Anti-JUUL
Prediction Not checkable as stated
Israel expects $375 revenue per customer based on 12-month retention
“On average, about 12 months so we should get around 375 dollars per customer, and the cost to us is around 85 to 125 dollars.”
Josh Israel Mar 3, 2025 ▶ 7:16 #79 The Anti-JUUL
Assertion Partly supported
Israel says FDA grants three to five years of market exclusivity
“So they have like three to five year exclusivity if we were to get approval and things of that nature.”
Josh Israel Mar 3, 2025 ▶ 9:38 #79 The Anti-JUUL
Disclosure
Israel says Hava Health device will cost $59 to $69
“Looking to price our device for around 59 or 69 dollars, and then a monthly subscription for around 30 to 40 dollars, which includes the replacement pods.”
Josh Israel Mar 3, 2025 ▶ 7:03 #79 The Anti-JUUL

The other half of the tape: Josh Israel's own voice is left out of every number here. 1 statement on the record names them. every mention, with the transcript →

Statements about Josh Israel, by other people (1)

Disclosure
Mohnot offers a $25,000 personal angel check to Hava Health
“I'd like to write, like, a small personal check of, like, 25 K. Sure. If you could fit me into the previous round.”
Sheel Mohnot Mar 3, 2025 ▶ 16:10 #79 The Anti-JUUL

Appearances (1)

EpisodeDateSpeaking time
#79 The Anti-JUUL Mar 3, 2025 9m
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more